INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
Aplastic Anemia (AA) is a rare condition with the probability of 2-6 cases per million per year occurrence. In this condition, bone marrow is not capable of forming new blood cells. There are various causes reported, e.g. Radiation, Chemicals, NSAIDS, as well as it can be a result of genetic alterations. It was discovered by Dr. Paul Ehrlich and named by Anatole Chauffard. Primary symptoms of AA are fatigue, weakness, dizziness, excessive bleeding and quick response to infection. The diagnosis of AA is a bone marrow biopsy. Though it is a serious condition with high life- threatening risk but it can be controlled and treated successfully although there is no definite cure found yet. Immunosuppressive agents and hematopoietic stem cell transplant (HCT) are majorly offered treatment along with other medications like antibiotics and bone marrow stimulators. The patient also must go through regular blood transfusions. As there are improvements in the provision of treatment and supportive measures, they have contributed to the increase in survival rate of patients
"Review on Aplastic Anemia", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.9, Issue 2, page no.442 - 445, February-2024, Available :http://www.ijsdr.org/papers/IJSDR2402064.pdf
Downloads:
000338719
Publication Details:
Published Paper ID: IJSDR2402064
Registration ID:210122
Published In: Volume 9 Issue 2, February-2024
DOI (Digital Object Identifier):
Page No: 442 - 445
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn